Trials / Conditions / Recurrent Urothelial Carcinoma
Recurrent Urothelial Carcinoma
4 registered clinical trials studyying Recurrent Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo NCT04963153 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney NCT00365157 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |